BRD4 and cancer: In contrast, BRD4 was overexpressed in colorectal cancers (Fig. 1c, d) and predicted significantly reduced survival (https://www.proteinatlas.org/ENSG00000141867-BRD4/pathology/colorectal+cancer, p = 0.0064).